ICH E9 and CDISC: The Master Formula for Excellence in Clinical Research and Data Management

by Sermes CRO

ICH E9 and CDISC share the goal of improving the quality and efficiency of clinical research and medicinal product development. Although they focus on different aspects of clinical data management, th...

Read more

Transforming Clinical Research through Artificial Intelligence

by Sermes CRO

he incursion of Artificial Intelligence (AI) and machine learning in Clinical Research has proven to be an effective tool for improving processes efficiency and accuracy of results

Read more

Analysis of Express Import Authorizations for medical devices

by Sermes CRO

Express import authorizations cover the use of a medical device in specific patients (individual authorizations), outside of the clinical research setting with medical devices, using devices that do n...

Read more

Clinical trials: the patient's perspective

by Sermes CRO

From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical t...

Read more

Nominal variables are more than just a name

by Sermes CRO

Some examples of classic nominal variables in clinical trials are the randomization group, sex, diagnosis, type of treatment, hospital where the patients were recruited, whether a certain medical test...

Read more

AEDESEO y Sermes CRO, colaborando para visibilizar la Esofagitis Eosinofílica

by Sermes CRO

AEDESEO, la Asociación Española de Esofagitis Eosinofílica, y Sermes CRO llegan a un acuerdo para trabajar juntos en acciones de comunicación dirigidas a visibilizar esta enfermedad y empoderar a ...

Read more

'Advanced Therapies are the medicine of the future': Mercedes Zurita, researcher and head of the Cell Therapy Unit at Puerta de Hierro Hospital

by Sermes CRO

Interview Dr. Mercedes Zurita, researcher at the Puerta de Hierro Hospital and head of the Cell Therapy Unit at this site, the only one in Spain to offer NC1 therapy for patients with spinal cord inju...

Read more

Esofagitis Eosinofílica: entrevistamos a la presidenta de AEDESEO, Miriam Espinosa

by Sermes CRO

“La esofagitis eosinofílica afecta mucho a la calidad de vida del paciente. No poder comer es de las cosas más limitantes de la vida. Los pacientes tienen problemas psicológicos, como miedo a com...

Read more

Sermes CRO: Novedades sobre el nuevo portal europeo de ensayos clínicos de la EMA (CTIs)

by Sermes CRO

​La Agencia Europea de Medicamentos (EMA) tiene como objetivo tener listo su sistema de información de ensayos clínicos (CTIS) en diciembre de 2021, comprometiéndose con este objetivo en la actua...

Read more

Sermes CRO and Quirónsalud have signed an agreement to collaborate in the development of Clinical Research Studies

by Sermes CRO

Sermes CRO, a company with more than 10 years dedicated to the health sector and clinical research, have signed an agreement with Quirónsalud for conducting clinical trials, observational studies and...

Read more

Sermes CRO seleccionado como Tester del Nuevo Portal Europeo de la EMA (UATs)

by Sermes CRO

La EMA (European Medicines Agency), retoma el desarrollo del Nuevo portal para la presentación online de ensayos clínicos a nivel europeo (UATs European Portal). Éste Octubre 2017 se llevará a cab...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Horizon pone en marcha una planta punter...

by Horizon Products

Horizon ha puesto en funcionamiento una nueva planta dedicada íntegra...

Photos Stream